Priscilla van der Wilk

Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial

H. Putter, R. Tollenaar, W. Mesker, 2019, Cellular Oncology.

The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes

R. Wolterbeek, H. Baelde, J. Bruijn, 2017, Diabetologia.

Stromal organization as predictive biomarker for the treatment of colon cancer with adjuvant bevacizumab; a post-hoc analysis of the AVANT trial

H. Putter, R. Tollenaar, W. Mesker, 2019, Cellular Oncology.